1. Home
  2. ELMT vs RLMD Comparison

ELMT vs RLMD Comparison

Compare ELMT & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Elmet Group Co. Common Stock

ELMT

The Elmet Group Co. Common Stock

N/A

Current Price

$20.17

Market Cap

474.9M

Sector

Industrials

ML Signal

N/A

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

N/A

Current Price

$4.63

Market Cap

515.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ELMT
RLMD
Founded
N/A
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
474.9M
515.2M
IPO Year
2026
2012

Fundamental Metrics

Financial Performance
Metric
ELMT
RLMD
Price
$20.17
$4.63
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$12.40
AVG Volume (30 Days)
282.0K
1.2M
Earning Date
N/A
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
45.28
EPS
N/A
N/A
Revenue
N/A
$13,070.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
154.83
52 Week Low
$12.49
$0.60
52 Week High
$20.91
$8.00

Technical Indicators

Market Signals
Indicator
ELMT
RLMD
Relative Strength Index (RSI) 66.50 35.72
Support Level $13.96 $4.06
Resistance Level N/A $4.97
Average True Range (ATR) 1.34 0.27
MACD 0.37 0.02
Stochastic Oscillator 95.96 25.71

Price Performance

Historical Comparison
ELMT
RLMD

About ELMT The Elmet Group Co. Common Stock

The Elmet Group Co provides precision-engineered components and high-energy systems for the Aerospace, Defense and Government, Industrial, Medical, Semiconductor and Electronics, and Energy industries. The company is organized into two business divisions, Critical Materials Components and Engineered Microwave Products, offering a platform with expertise across interconnected markets. The company operates an integrated engineering-to-production system, covering custom design, development, and processing across Critical Materials and High-Power Microwave. Its Engineered Microwave capabilities helps to deliver tailored microwave energy solutions, while its Critical Materials expertise allows to design reliable solutions for some of the demanding environments in the world.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.

Share on Social Networks: